Newbridge Financial Services Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Newbridge Financial Services Group's AZN Position: Q2 2026 in Review
Newbridge Financial Services Group increased its AstraZeneca (AZN) stake by 169% in Q2 2026, buying an estimated $133K and bringing the position to 1,128 shares worth $214K. The position accounts for 0.03% of the portfolio, ranked #240.
Newbridge Financial Services Group first reported a position in AZN in Q3 2020 and has held it in 22 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Newbridge Financial Services Group held 1,128 shares of AstraZeneca worth $214K as of Q2 2026.
- Newbridge Financial Services Group bought 709 AstraZeneca shares in Q2 2026, an estimated $133K.
- AstraZeneca made up 0.03% of Newbridge Financial Services Group's portfolio in Q2 2026, its #240 holding.
- Newbridge Financial Services Group first reported a position in AstraZeneca in Q3 2020 and has held it in 22 quarters since.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.